The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer
Clinical trial NCT06242392 · UNKNOWN
Trial details
- NCT number
- NCT06242392
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-31
- Primary completion
- 2026-05-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.